CONSTELLATE helps protein-based therapeutics developers roll out life-saving drugs faster by accelerating critical analyses in drug development.
To produce a protein-based therapeutic, developers employ living cells. These cells often modify the therapeutic by, for instance, attaching large sugar molecules to it. It is critical to monitor such modifications as they influence the activity and stability of the therapeutic and, therefore, its safety and effectivity. Constellate offers a new technology to monitor these modifications at the single molecule level, allowing fast turnaround at a fraction of the cost of current technologies.
Biotech Booster supports the development of a technical proof of concept and the go-to-market strategy.
Learn more about this innovation through their website: https://www.constellate.pro/
